diabetestalk.net

FDA Approves The First Automated Insulin System For Type 1 Diabetes

FDA Approves The First Automated Insulin System For Type 1 Diabetes

FDA Approves The First Automated Insulin System For Type 1 Diabetes

The Food and Drug Administration's approval of a new insulin delivery system for people with Type 1 diabetes is a big deal.
With Type 1 diabetes, the pancreas makes little or no insulin so people have to replace it with either multiple daily injections or a pump. In either case, that process involves constant error-prone adjustments, particularly around food and exercise. Over the long term, high blood sugar levels can lead to organ damage, but over-correcting by giving more insulin can cause dangerous low blood sugars that can lead to unconsciousness.
The device, Medtronic's MiniMed 670G hybrid closed loop system, is made up of an insulin pump and continuous glucose monitor (CGM), both of which are already on the market separately. The new part involves the communication between the two devices.
Medtronic's previous system already had a feature that would shut down the insulin pump if the wearer's blood sugar dropped too low. But the 670G predicts when a person's blood sugar is dropping and prevents the low in the first place, and also corrects high blood sugars.
This is the first such machine in the world with that level of automation, and thus it is informally being called the first "artificial pancreas" system.
However, it's called a hybrid rather than a fully closed-loop system because users will still need to signal that they're about to eat and estimate the carbohydrate count of the food so the device can calculate the additional amount of insulin needed. That means there's still the possibility of mistakes. But now if that count is off, the 670G will correct the err Continue reading

Rate this article
Total 1 ratings
This Teenager Wants You To Know What Diabetes Really Looks Like

This Teenager Wants You To Know What Diabetes Really Looks Like

This is Madeline Milzark, an 18-year-old from Missouri. She's had type 1 diabetes for almost 10 years now.
There are three main types of diabetes: type 1, type 2, and gestational diabetes. While both type 1 and type 2 are chronic conditions, type 1 is typically diagnosed in children, and type 2 is often diagnosed later in life. Gestational diabetes is a form of diabetes that occurs during pregnancy.
Last week Milzark wrote a Facebook post about what it's like to live with diabetes, and people have been sharing it across the globe.
"It's a disease that isn't picky when it chooses who to attack, it doesn't care if you're 2 months old or if you're 73. It doesn't care if you eat Big Macs and McChickens every day of your life or if you're a strict vegan who goes to the gym daily. Diabetes is me. Diabetes is a whole ton of people who fight for their life every single day and go to bed not sure if they're going to wake up the next morning. So before you tag your huge dessert #Diabetes, think about what #Diabetes really looks like".
Madeline says she's received hundreds of positive messages from the post, which has been shared over 5,000 times.
Facebook / Via facebook.com
She decided to write the post after her blood sugar crashed, resulting in her collapsing while home alone. It was sugar supplied by her grandmother that saved her life.
Madeline had her phone at the time and was able to text her grandmother, who brought her the sugar: "If she didn't there was no telling how long it would've taken her to find me and it would've probably been too late by then."
"I have to monitor my Continue reading

Insulin pill may delay type 1 diabetes in some

Insulin pill may delay type 1 diabetes in some

(HealthDay)—It's often said that timing is everything. New research suggests this may be true when giving an insulin pill to try to prevent or delay type 1 diabetes.
Researchers tested the effect of insulin pills on 560 children and adults whose relatives had type 1 diabetes. For most of them, the drug had no effect on whether or not they developed type 1 diabetes, or how quickly they developed it.
But for those at the highest risk of developing type 1 diabetes sooner rather than later, insulin pill therapy delayed the time it took to develop the full-blown disease by about two-and-a-half years, the researchers said.
"This is the largest study using oral insulin," said the study's lead author, Dr. Carla Greenbaum. Participants also had known autoantibodies that indicated a very high risk of developing type 1 diabetes in their lifetimes, said Greenbaum, chair of Diabetes TrialNet.
Jessica Dunne, director of discovery research for JDRF (formerly the Juvenile Diabetes Research Foundation), called the results "a huge success."
"We finally, for the first time, have been able to show a delay in the progression of type 1 diabetes," said Dunne. But the findings need to be replicated in additional studies, she added.
Type 1 diabetes is an autoimmune disease. It's far less common than type 2 diabetes, which is linked to excess weight and a sedentary lifestyle.
Insulin is a naturally occurring hormone. It's necessary for ushering the sugar from food into the body's cells for fuel. People with type 1 diabetes have little to no insulin because their immune system mistakenly attacked h Continue reading

Your child is diagnosed with Type 1 diabetes. These families have been there

Your child is diagnosed with Type 1 diabetes. These families have been there

Brooke Miller, a college freshman at the University of Florida, was diagnosed with Type 1 diabetes at age 3.
“I don’t really remember my life without it because I was so young,” says the 18-year-old.
Her earliest memories are of feeling tired at school and her mother coming to give her insulin injections. She also remembers sitting on the kitchen floor at her Weston home trying to prick her finger to check her blood-sugar levels. “I wanted to be independent and do it on my own.”
Over the last 10 years, however, new technology such as the continuous glucose monitor (CGM) and insulin pump have been introduced and are becoming more sophisticated, allowing patients such as Miller more freedom and power over managing their condition.
Never miss a local story.
Sign up today for a free 30 day free trial of unlimited digital access.
SUBSCRIBE NOW
When Miller started using a CGM four years ago, providing her with a 24-7 reading of her glucose levels, she went from having to prick her finger six to seven times a day to calibrating the device and pricking her finger only two to three times per day. The CGM communicates with an insulin pump, which maintains the body’s glucose levels.
Brooke Miller has Type 1 diabetes.
ADP Andrew Duany
In Type 1 diabetes, the body’s immune system attacks part of the pancreas, destroying insulin-producing cells called islets. This leads to either no insulin produced or a severe shortage of the valuable hormone. It also results in dangerously high blood sugar levels, which can damage eyes, kidneys, nerves and the heart, and can lead to diabe Continue reading

CMS Must Ensure Seniors Have Access to Diabetes Prevention Resources

CMS Must Ensure Seniors Have Access to Diabetes Prevention Resources

The scourge of type 2 diabetes across the United States costs American taxpayers billions of dollars every single year. Diabetes and diabetes-related treatment is one of the biggest drivers of rising health care costs for every payer — with Medicare spending more on treating those with the disease every year. This is particularly true in rural America, as the prevalence of diabetes and coronary heart disease is approximately 17 and 39 percent higher in rural areas than urban areas.
Policymakers from both sides of the aisle recognize this reality, and have embraced the challenge of confronting a preventable, but devastating, epidemic. Last month, for the first time in the agency’s history, the Centers for Medicare and Medicaid Services laid out proposed rules to reimburse providers to proactively prevent chronic disease by paying for the evidence-based Diabetes Prevention Program for eligible beneficiaries. Last year, the CMS Actuary certified that this program both improved quality of care and reduced costs for Medicare.
But unfortunately, the proposed rule missed a huge opportunity to extend access to this benefit to the area most in need: rural America.
In the July 13 rule, CMS proposed only making in-person DPP providers eligible for reimbursement, despite enormous evidence that virtual providers can achieve equal, or even better, results with senior populations. In addition, CMS’ sister agency, the Centers for Disease Control and Prevention, has been recognizing digital programs for more than two years while also collecting data demonstrating these programs’ eff Continue reading

No more pages to load

Popular Articles

  • News Flash: The FDA Just Approved a Breakthrough Diabetes Device

    Diabetes is often referred to in the medical community as the "silent killer." Affecting more than 30 million people in the U.S. (9.4% of the population), diabetes was listed the cause of death for nearly 80,000 people in 2016, according to the Centers for Disease Control and Prevention. Its comorbidities, such as hypertension, heart disease, and kidney disease, can also cause lifelong problems an ...

  • Leading Diabetes Groups Publish Consensus Statement on "Beyond A1C" Measures to Guide FDA, Researchers

    The Beyond A1C movement seeks regulatory and clinical are frameworks that recognize the day-to-day measures that matter to patients, such as how often they experience hypoglycemia. After 2 years of work, a consortium of leading diabetes groups published a statement Tuesday that they hope will guide the FDA when it evaluates how drugs and devices affect the everyday health of people with type 1 dia ...

  • Abbott wins FDA approval for diabetes device that doesn't require routine finger pricks

    Abbott wins FDA approval for diabetes device that doesn't require routine finger pricks October 4, 2017 by Lisa Schencker, Chicago Tribune Abbott Laboratories has gained clearance to start selling in the U.S. the first continuous glucose monitor that does not require people with diabetes to routinely prick their fingers. The U.S. Food and Drug Administration recently approved Abbott's FreeSty ...

  • Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes

    Abstract In adulthood, autoimmune diabetes can present as non-insulin-requiring diabetes, termed as ‘latent autoimmune diabetes in adults’ (LADA). In this study, we investigated established type 1 diabetes (T1D) and type 2 diabetes (T2D) genetic loci in a large cohort of LADA cases to assess where LADA is situated relative to these two well-characterized, classic forms of diabetes. We tested t ...

  • Parents who refused to treat dead son’s diabetes with insulin charged with first-degree murder

    Rodica Radita didn’t want to accept that her son had Type-1 diabetes. She and her husband’s refusal to treat their son’s illness resulted in numerous hospitalizations over 12 years, until their son Alex died at 15-years-old in 2013 – weighing just 37 pounds. Now, the Raditas have been charged with first-degree murder in connection to their son’s death. After his initial diagnosis, Alex R ...

  • First patient in diabetes trial no longer needs insulin therapy

    MIAMI, Sept. 10 (UPI) -- The first patient to receive therapeutic delivery of islet cells in a new diabetes study no longer needs insulin therapy to control type 1 diabetes, according to doctors at the University of Miami's Diabetes Research Institute. The patient, Wendy Peacock, 43, has been giving herself insulin injections to control diabetes since she was diagnosed with the condition at age 17 ...

  • New Drug Appears To Eliminate Type 2 Diabetes For First Time

    Type 2 diabetes, although influenced by a person’s genes, is largely thought to be brought about by a poor diet and being overweight for prolonged periods of time, particularly at an old age. The pancreas is either unable to produce enough insulin, or the body’s cells simply don’t react to insulin, which leads to dangerously high blood sugar levels. This is known as insulin resistance, and a ...

  • More than 500 children with Type 2 diabetes - just 16 years after first ever case

    More than 500 children in England and Wales are now suffering from type 2 diabetes, just 16 years after the first reported case. The figures in the National Paediatric Diabetes Audit have been branded a “wake-up call for the nation”, as the Government faces calls to tackle the rising levels of childhood obesity which is fueling the diabetes surge. Unlike type 1 diabetes, type 2 is largely prev ...

  • Type 2 diabetes breakthrough: Scientists create first pill that not only STOPS the condition in its tracks but also helps patients lose weight - and it could be available on the NHS within 3 years

    Scientists have created a new pill that can halt type 2 diabetes in its tracks and help patients shed pounds from their waistlines, a major study has revealed. Results from a human trial of 632 patients found semaglutide allowed 71 per cent of them to shed pounds - it is believed this is the first type 2 diabetes pill to instigate weight loss. Researchers hope semaglutide will offer a better way t ...

Related Articles